Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AiLAB is a Swiss medical technology company specializing in the development of artificial intelligence solutions for dermatological diagnostics. The company's core offering is an AI-driven platform designed to assist healthcare professionals in the early detection and classification of skin cancer and other dermatological conditions. By utilizing deep learning algorithms trained on extensive clinical datasets, AiLAB provides high-accuracy assessments of skin lesions, including melanoma and non-melanoma skin cancers. Their technology aims to bridge the gap between general practitioners and specialist dermatologists, improving patient triage and outcomes through more accessible expert-level screening. AiLAB's products are integrated into clinical workflows to enhance diagnostic efficiency and accuracy in skin health monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AiLABSWISS.